'Some Hope Is Better Than Having No Hope'

After days of promising that a cease-fire was near, President Trump announced late Sunday that he had reached a deal with Iran. Today, David Sanger, who spoke to the president, explains what is and is not included in the framework agreement, and how much closer it gets both sides ...  Show more

Almost 50 years ago, Steven Spielberg directed “Close Encounters of the Third Kind,” the story of an average man who discovers that humanity may not be alone in the universe. Over the decades, Spielberg has directed several movies about what would happen if humanity made contact ...  Show more

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ...  Show more

The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For ...  Show more

Aduhelm, known generically as aducanumab, is the first drug to actually affect the underlying disease process associated with Alzheimer's. Yet sales have been limited, and the drug is reaching very few patients — at least so far. It's expensive, risky and likely doing little to i ...  Show more

An overwhelming demand for ADHD diagnoses has left the NHS struggling to keep up. What’s behind the rise?

Content warning: This episode contains mentions of suicidal thoughts and eating disorders.

This podcast was brought to you thanks to the s ...